Investment Analysts’ upgrades for Tuesday, August 29th:

Berkshire Hathaway (NYSE:BRK.B) was upgraded by analysts at Vetr from a hold rating to a strong-buy rating. The firm currently has $204.74 target price on the stock.

Computacenter plc (LON:CCC) was upgraded by analysts at Berenberg Bank to a buy rating. The firm currently has GBX 1,200 ($15.52) target price on the stock, up from their previous target price of GBX 750 ($9.70).

4imprint Group plc (LON:FOUR) was upgraded by analysts at Berenberg Bank to a buy rating. They currently have GBX 2,000 ($25.87) price target on the stock, up from their previous price target of GBX 1,950 ($25.22).

Hostelworld Group PLC (LON:HSW) was upgraded by analysts at Berenberg Bank to a buy rating. They currently have GBX 370 ($4.79) target price on the stock, up from their previous target price of GBX 270 ($3.49).

Iteris (NYSE:ITI) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. They currently have $6.75 price target on the stock. According to Zacks, “Iteris, Inc. is a leading provider of outdoor vision systems and sensors that optimize the flow of traffic and enhance driver safety. Iteris combines outdoor image processing, traffic engineering, and information technology to offer a broad range of transportation and safety solutions. “

Johnson Matthey PLC (NASDAQ:JMPLY) was upgraded by analysts at Zacks Investment Research from a sell rating to a hold rating. According to Zacks, “Johnson Matthey Plc is a speciality chemicals company focused on its core skills in catalysis, precious metals, fine chemicals and process technology. Its principal activities comprise manufacture of autocatalysts, heavy duty diesel catalysts and pollution control systems, catalysts and components for fuel cells, catalysts and technologies for chemical processes, fine chemicals, chemical catalysts and active pharmaceutical ingredients. The Company also engages in the marketing, refining, and fabrication of precious metals. Its environmental technologies include emission control technologies, process technologies and fuel cells. Its precious metals products include platinum, noble metals, catalysts, chemicals and refining and colour technologies. Its fine chemicals include macfarlan smith, pharmaceutical materials and services and research chemicals. Johnson Matthey Plc is headquartered in London, U.K. “

Kilroy Realty Corporation (NYSE:KRC) was upgraded by analysts at Zacks Investment Research from a sell rating to a hold rating. According to Zacks, “Kilroy Realty Corporation owns, operates and develops commercial and industrial properties, primarily in California, Washington, and Arizona. At March 31, 1997, the Company owned 2.0 million square feet of commercial office space and 1.3 million square feet of industrial space. “

Kura Oncology (NASDAQ:KURA) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. They currently have $7.75 price target on the stock. According to Zacks, “Kura Oncology, Inc. is a biopharmaceutical company. The company is involved in the discovery and development of therapeutics for the treatment of tumors and blood cancers. Its product pipeline includes small molecule drug candidates which are in different clinical trial consists of Tipifarnib-HRAS, Tipifarnib-PTCL, ERK inhibitor program and Menin MLL inhibitor program. Kura Oncology, Inc. is headquartered in La Jolla, California. “

Linde Ag Spon (NASDAQ:LNEGY) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. Zacks Investment Research currently has $22.00 price target on the stock. According to Zacks, “The Linde Group is an engineering company which supplies industrial, process and specialty gases worldwide. The Company’s core operating segments consist of the gases and engineering division. The main gases produced by the Company are acetylene, carbon dioxide, nitrogen, hydrogen, shielding gases for welding applications, noble gases, calibration gas mixtures, high-purity gases and gas mixtures. It also supplies welding and safety products. Lindes’s pharmaceutical and medical gas products and services find their use in clinical care, emergency care, and ventilation therapy and hospital infrastructure. The engineering division focuses on plant engineering for the production of hydrogen and synthesis gas, oxygen and olefins as well as plants for natural gas treatment. The Company’s non core division the gist division operates in a wide range of commercial and industrial sectors including grocery, retail, electronics and gas. . The Linde Group is headquartered in Munich, Germany. “

Manhattan Associates (NASDAQ:MANH) was upgraded by analysts at Zacks Investment Research from a sell rating to a hold rating. According to Zacks, “Manhattan Associates is a leading provider of technology-based solutions to improve supply chain effectiveness and efficiencies. The company’s solutions enhance distribution efficiencies through the integration of supply chain constituents, including manufacturers, distributors, retailers, suppliers, transportation providers and end consumers. Their solutions consist of software; services, including design, configuration, implementation, and training services, plus customer support and software upgrades; and hardware. “

Millennium & Copthorne Hotels plc (LON:MLC) was upgraded by analysts at Berenberg Bank to a hold rating. The firm currently has GBX 450 ($5.82) target price on the stock, up from their previous target price of GBX 380 ($4.91).

Schroders plc (LON:SDR) was upgraded by analysts at Macquarie to a neutral rating. The firm currently has GBX 3,031 ($39.20) price target on the stock.

Skyworks Solutions (NASDAQ:SWKS) was upgraded by analysts at Vetr from a buy rating to a strong-buy rating. Vetr currently has $114.47 price target on the stock.

Ubiquiti Networks (NASDAQ:UBNT) was upgraded by analysts at Vetr from a buy rating to a strong-buy rating. The firm currently has $69.54 target price on the stock.

Exxon Mobil Corporation (NYSE:XOM) was upgraded by analysts at Vetr from a hold rating to a buy rating. They currently have $79.60 price target on the stock.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.